Swiss National Bank Allakos Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$3.6 - $5.25 $37,800 - $55,125	10,500 Added 12.7%	93,200 $406,000
Q1 2023 May 10, 2023	SELL	$4.3 - $8.27 $304,440 - $585,516	-70,800 Reduced 46.12%	82,700 $368,000
Q4 2022 Feb 08, 2023	BUY	$5.66 - $8.42 $868,810 - $1.29 Million	153,500 New	153,500 $1.29 Million
Q2 2022 Aug 09, 2022	SELL	$2.6 - $6.14 $200,460 - $473,394	-77,100 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.08 - $9.81 $29,464 - $56,898	5,800 Added 8.13%	77,100 $439,000
Q4 2021 Feb 08, 2022	BUY	$8.55 - $111.89 $2,565 - $33,567	300 Added 0.42%	71,300 $698,000
Q3 2021 Nov 08, 2021	BUY	$76.53 - $110.43 $122,448 - $176,688	1,600 Added 2.31%	71,000 $7.52 Million
Q2 2021 Aug 06, 2021	BUY	$85.37 - $114.1 $802,478 - $1.07 Million	9,400 Added 15.67%	69,400 $5.93 Million
Q1 2021 May 07, 2021	BUY	$109.73 - $153.66 $515,731 - $722,202	4,700 Added 8.5%	60,000 $6.89 Million
Q3 2020 Nov 09, 2020	BUY	$66.43 - $90.99 $59,787 - $81,891	900 Added 1.65%	55,300 $4.5 Million
Q2 2020 Aug 05, 2020	BUY	$44.04 - $80.69 $317,088 - $580,968	7,200 Added 15.25%	54,400 $3.91 Million
Q1 2020 May 08, 2020	BUY	$44.49 - $93.39 $40,041 - $84,051	900 Added 1.94%	47,200 $2.1 Million
Q4 2019 Feb 06, 2020	BUY	$66.49 - $137.73 $99,734 - $206,594	1,500 Added 3.35%	46,300 $4.42 Million
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $641,700 - $1.86 Million	20,700 Added 85.89%	44,800 $3.52 Million
Q2 2019 Aug 02, 2019	SELL	$36.0 - $44.73 $237,600 - $295,218	-6,600 Reduced 21.5%	24,100 $1.04 Million
Q1 2019 May 10, 2019	BUY	$33.79 - $51.99 $533,882 - $821,442	15,800 Added 106.04%	30,700 $1.24 Million
Q4 2018 Feb 13, 2019	BUY	$31.59 - $62.65 $470,691 - $933,485	14,900 New	14,900 $779,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$21 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.81 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.35 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.46 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.91 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account